Summary The effects of various chemotherapeutic agents on alpha-fetoprotein (AFP) secretion and growth of human hepatocellular carcinoma and hepatoblastoma cell lines were investigated in vitro. It was found that there was a high correlation between hepatoma cell number and AFP secretion after treatment and that the amount of AFP secreted per cell per 72h was not affected with therapeutically achievable concentrations. These results suggest that serum AFP level in patients with hepatomas does not correlate with the size of whole tumour but with that of viable tumour mass, and that AFP-secreting capacity of tumour cells in the mass is kept unchanged after chemotherapy.
Serum level of alpha-fetoprotein (AFP) is often increased in patients with hepatocellular carcinoma (HCC) or hepatoblastoma, and therefore the expression of AFP has served as a reliable tumour marker for diagnosis or therapy of HCC or hepatoblastoma. Many studies have been concerned with the correlation between AFP levels and tumour mass in patients (Johnson & Williams, 1980; Pritchard et al., 1982) or animals (Lo et al., 1973; Tsukada et al., 1974; Sell et al., 1974) with hepatoma. The relationship of serum AFP concentration to tumour mass was examined using human hepatocellular carcinoma cell line PLC/PRF/5-bearing nude mice, for the purpose of validating the use of changes in serum AFP level as a means of following response to therapy, and it was concluded that there was a positive correlation between serum AFP level and total tumour burden (Bassendine et al., 1983) . However, it seemed to be difficult to estimate whether or not the AFP-producing capacity of hepatoma cells was affected by treatment with chemotherapeutic agents from their whole tumour study.
We examined in this study the change of secretion of AFP and that of cell number by treatment of human hepatocellular carcinoma and hepatoblastoma cells with various chemotherapeutic agents in vitro.
Materials and methods

Cell lines
Human well-differentiated hepatocellular carcinoma (HuH-7) (Nakabayashi et al., 1982) and well-differentiated hepatoblastoma (HuH-6) (Doi, 1976) cell lines were used. The population doubling times of HuH-7 and HuH-6 were 46.3 h and 83.1 h, respectively. The culture media used were RPMI-1640 (Nissui-Seiyaku, Japan) supplemented with 0.2% lactalbumin hydrolysate (Difco) and 2% bovine serum (BS) with 60pgml-1 of kanamycin sulphate (Meiji-Seika, Japan). All dishes were kept at 37°C in a humidified atmosphere of 5% CO2 and 95% air.
Chemotherapeutic agents Mitomycin C (MMC), Adriamycin (ADM), 5-fluorouracil (5-FU) (Kyowa-Hakko, Japan) and cisplatinum (CDDP) (Nihon-Kayaku, Japan), which have been commonly used for the clinical treatment of hepatomas, were used as test agents. All agents were diluted to final concentration in the fresh medium and were used immediately for the experiment. Cultured cells were treated with chemotherapeutic agents to at least four concentrations including the therapeutically achievable range, which is one-tenth the peak plasma concentration in human pharmacokinetics studies (3 x 10-7 M for MMC, 7xlF-8M for ADM, 6x10-7M for CDDP and 5 x O-I M for 5-FU) (Von Hoff et al., 1981 (P<0.05), respectively, and that of HuH-6 was 0.51 (not significant), 0.82 (P<0.01), 0.84 (P<0.01) and 0.84 (P <0.01), respectively.
The higher correlation was found in the case of ADM and CDDP in both HuH-7 and HuH-6. As shown in Tables I  and II, aSignificantly different from control (P <0.01). Discussion AFP has been a useful tool for diagnosis and indicator after treatment such as surgical operation, chemotherapy, transcatheter arterial embolization (TAE), hyperthermia and so on (Matsumoto et al., 1974; McIntire et al., 1976; Johnson et al., 1978) . There are some early reports including studies on choriocarcinomas that serum or tumour AFP level does not correlate with tumour mass (Purves et al., 1970; Masseyeff, 1978; Raghavan et al., 1980) . On the other hand, positive correlations between them have also been demonstrated by patient studies (Johnson & Williams, 1980) or model systems where mice transplanted with a human hepatocellular carcinoma cell line PLC/PRF/5 were used (Bassendine et al., 1983; Curtin et al., 1986) . In the latter study, however, it seemed to be difficult to obtain reliable estimates of viable tumour mass and the amount of AFP secreted per cell because of the inclusion of many necrotic portions, especially after treatment. Thus, highly AFP-producing human hepatoma cell lines seem to be a suitable model for investigation of the growth capacity of cells or the amount of AFP secreted per cell. Few cell lines, however, have been available for such studies so far. The present studies were carried out using two human hepatocellular carcinoma and hepatoblastoma cell lines which were established in our laboratory and retained high AFP-producing capacity even in culture. These results show: (a) that there is a high correlation between tumour cell number and AFP secretion after treatment in vitro, corresponding to the data that were obtained by the patient studies or model systems described above; and (b) Growth inhibition (% control) that the amount of AFP secreted per cell was not affected, with only one exception, by the treatment of cells with therapeutically achievable concentrations of chemotherapeutic agents, but affected with higher concentrations of some agents. These data suggest that serum AFP level in patients correlates with the size of viable tumour mass rather than that of whole tumour, and that AFP-secreting capacity of tumour cells in the tumour mass is kept unchanged after chemotherapy. Chemotherapeutic agents at above 10-4 M seem to be toxic to the cells. In fact, many non-viable or morphological impaired cells were observed at these concentrations (data not shown). It seems likely that the data at higher concentration do not reflect exactly the AFP-secreting capacity of cells. Not only therapeutically achievable concentration, but also area under the concentration curve (AUC) are important as pharmacokinetic parameters of drug behaviour (Salmon, 1984; Slee et al., 1986) . The AUC is defined as the product of concentration and exposure time. It was found that the concentrations used in the present study were still valid by using these AUCs.
Despite the development of diagnosis, world-wide primary hepatomas have been one of the most lethal diseases (Liver Cancer Study Group of Japan, 1984; Dunk et al., 1988) , and the exploitation of new effective chemotherapeutic agents has been needed. In vitro culture systems using highly AFPproducing hepatoma cell lines may provide a new drug screening model for hepatomas.
